Zuellig Pharma Specialty Solutions (India) Private Limited

Zuellig Pharma Specialty Solutions (India) Private Limited - transport and logistics in Bhiwandi, Maharashtra, India. FY 2026 financials & compliance.
CIN U74120MH2015FTC262353 Incorporated 02 March 2015 ROC Mumbai HQ Bhiwandi, Maharashtra, India
Active Foreign Private Limited Company transport and logistics
Revenue · FY 2025
₹11.78 Cr
▼ 31.96% YoY
Net profit · FY 2025
₹77.64 Lakh
Net margin 6.6%
EBITDA · FY 2025
₹1.42 Cr
EBITDA margin 12.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹39.4 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Zuellig Pharma Specialty Solutions (India) Private Limited

Data last updated:

Zuellig Pharma Specialty Solutions (India) Private Limited is a foreign private limited company based in Bhiwandi, Maharashtra, India, a subsidiary of Zuellig Pharma Speciality Solutions Group Pte Ltd. It operates in the integrated logistics and supply chain solutions segment of the transport and logistics sector. It was incorporated on 02 March 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2015FTC262353. Its GSTIN is 27AAACZ8262G1Z1 (Maharashtra).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹39.4 Lakh. It is led by directors including Evasio Barbero and Giuseppe Leo.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No – 16 17A & 17B Building No – B1 City Link Warehousing Complex, Mumbai Nasik Highway Village – Vadape Bhiwandi Thane, Maharashtra, India – 421302.

As per the financials filed for FY 2025, the company reported a revenue of ₹11.78 Cr. For the same year it recorded a net profit of ₹77.64 Lakh (net margin 6.6%) and EBITDA of ₹1.42 Cr (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 16% over five years.

The company is associated with 1 brand: Zuellig Pharma.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zuelligpharma.com.

Company details

CIN U74120MH2015FTC262353
Registration Number 262353
Incorporation Date 02 March 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Zuellig Pharma Speciality Solutions Group Pte Ltd
Compliance Status Active Compliant

Contact details

Zuellig Pharma Specialty Solutions (India) Private Limited's registered office is in Bhiwandi, Maharashtra. Its website is zuelligpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Gala No – 16 17A & 17B Building No – B1 City Link Warehousing Complex, Mumbai Nasik Highway Village – Vadape Bhiwandi Thane, Maharashtra, India – 421302
  • Industry
    Transport and Logistics, Integrated & Diversified Logistics Services

To see the full contact details of Zuellig Pharma Specialty Solutions (India) Private Limited, buy the company report.

Comprehensive company report
Zuellig Pharma Specialty Solutions (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Zuellig Pharma Specialty Solutions (India) operates one associated brand: Zuellig Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Healthcare access in Asia is enhanced by Zuellig Pharma.zuelligpharma.com

Business activity

The main business activity of Zuellig Pharma Specialty Solutions (India) is transport and storage. In detail, this covers warehousing and storage.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
HTransport and storageH6Warehousing and storage

To see the full business activity and turnover split of Zuellig Pharma Specialty Solutions (India) Private Limited, buy the company report.

Financials of Zuellig Pharma Specialty Solutions (India) Private Limited

FY 2025 filings available

Zuellig Pharma Specialty Solutions (India) Private Limited reported revenue of ₹11.78 Cr for FY 2025.

Revenue · FY 2025
₹11.78 Cr
Net profit · FY 2025
₹77.64 Lakh margin 6.6%
EBITDA · FY 2025
₹1.42 Cr margin 12.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 33%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 16%
5 years · compounded
▲ 9%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.42 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹77.64 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.1%
Net Profit Margin6.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Zuellig Pharma Specialty Solutions (India) Private Limited, buy the company report.

Board of directors of Zuellig Pharma Specialty Solutions (India) Private Limited

Zuellig Pharma Specialty Solutions (India) has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Evasio BarberoDirector14 Jan 20224 Years 9 MonthsCurrent
Giuseppe LeoDirector03 Mar 201511 Years 8 MonthsCurrent
Dharmesh Jayendrakumar ParikhDirector16 Jul 20215 Years 3 MonthsCurrent
Chee Peng LimDirector21 Feb 20233 Years 8 MonthsCurrent

Auditor

Zuellig Pharma Specialty Solutions (India) Private Limited is audited by B S R & CO LLP for the financial year 2022.

Auditor firmFinancial yearFirm registration number
B S R & CO LLPFY 2022101248W/W100022

Shareholding

The shareholding of Zuellig Pharma Specialty Solutions (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Zuellig Pharma Specialty Solutions (India) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Zuellig Pharma Specialty Solutions (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Zuellig Pharma Specialty Solutions (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACZ8262G1Z1MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Zuellig Pharma Specialty Solutions (India) Private Limited, buy the company report.

Recent activity

Zuellig Pharma Specialty Solutions (India) Private Limited has 10 board changes on record since 2015: 4 appointments and 6 cessations. The latest: Chee Peng Lim was appointed as Director on 21 Feb 2023.

AGM
Zuellig Pharma Specialty Solutions (India) Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Zuellig Pharma Specialty Solutions (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Chee Peng Lim was appointed as Director.
Ceased
Evasio Barbero ceased to be Additional Director.
Appointed
Evasio Barbero was appointed as Director.
Ceased
Dharmesh Jayendrakumar Parikh ceased to be Additional Director.
Ceased
Timothy Toi Ming Hui ceased to be Director.
Appointed
Dharmesh Jayendrakumar Parikh was appointed as Director.
Ceased
Jayanti Palassena Vaidyanath ceased to be Director.
Ceased
Georg Felix Schulz ceased to be Director.
Ceased
Giuseppe Leo ceased to be Additional Director.
Appointed
Giuseppe Leo was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Zuellig Pharma Specialty Solutions (India) is an active foreign private limited company based in Bhiwandi, Maharashtra, India. The company works in integrated and diversified logistics services, within the transport and logistics industry. It was incorporated on 02 March 2015 (11+ years old) and is registered under CIN U74120MH2015FTC262353.

Zuellig Pharma Specialty Solutions (India) has 4 current directors:

The latest financial statements of Zuellig Pharma Specialty Solutions (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Zuellig Pharma Specialty Solutions (India) is 27AAACZ8262G1Z1, registered in Maharashtra.

The CIN (Corporate Identification Number) of Zuellig Pharma Specialty Solutions (India) is U74120MH2015FTC262353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Zuellig Pharma Specialty Solutions (India) was incorporated on 02 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.

Chee Peng Lim was appointed as Director on 21 Feb 2023. Evasio Barbero ceased to be Additional Director on 05 Dec 2022. Evasio Barbero was appointed as Director on 14 Jan 2022. Zuellig Pharma Specialty Solutions (India) has 10 board changes on record in total.

Zuellig Pharma Specialty Solutions (India) can be reached through the website zuelligpharma.com. Its registered office is in Bhiwandi, Maharashtra, India.

The registered office of Zuellig Pharma Specialty Solutions (India) is at Gala No – 16 17A & 17B Building No – B1 City Link Warehousing Complex, Mumbai Nasik Highway Village – Vadape Bhiwandi Thane, Maharashtra, India – 421302.

Zuellig Pharma Specialty Solutions (India) operates in the transport and logistics industry, in the integrated and diversified logistics services segment.